Australia markets closed

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
68.53-0.38 (-0.55%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
25,564,000
24,689,000
22,449,000
22,127,000
26,107,000
Cost of revenue
4,964,000
4,572,000
4,675,000
4,853,000
4,371,000
Gross profit
20,600,000
20,117,000
17,774,000
17,274,000
21,736,000
Operating expenses
Research development
5,090,000
5,039,000
9,106,000
5,018,000
3,734,000
Selling general and administrative
5,130,000
5,151,000
4,381,000
4,056,000
3,878,000
Total operating expenses
10,220,000
10,190,000
13,487,000
9,074,000
7,612,000
Operating income or loss
10,380,000
9,927,000
4,287,000
8,200,000
14,124,000
Interest expense
1,000,000
984,000
995,000
1,077,000
1,118,000
Total other income/expenses net
-7,450,000
-7,274,000
1,868,000
676,000
523,000
Income before tax
1,930,000
1,669,000
5,160,000
7,799,000
13,529,000
Income tax expense
1,657,000
1,580,000
-204,000
2,339,000
8,885,000
Income from continuing operations
273,000
89,000
5,364,000
5,460,000
4,644,000
Net income
301,000
123,000
5,386,000
5,455,000
4,628,000
Net income available to common shareholders
301,000
123,000
5,386,000
5,455,000
4,628,000
Basic EPS
-
0.10
4.24
4.20
3.54
Diluted EPS
-
0.10
4.22
4.17
3.51
Basic average shares
-
1,257,000
1,270,000
1,298,000
1,307,000
Diluted average shares
-
1,263,000
1,277,000
1,308,000
1,319,000
EBITDA
-
4,133,000
7,559,000
10,305,000
15,933,000